Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer
NCT04986371
·
clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
UNKNOWN
Sponsor class
Conditions
Epithelial Ovarian Cancer
Interventions
DRUG:
Niraparib
Sponsor
Ling-Ying Wu